Parfenac.
D000287:Administration, Topical; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002019:Bufexamac / Q000009:adverse effects; D004485:Eczema / Q000188:drug therapy; D006801:Humans; D051381:Rats
D000893:Anti-Inflammatory Agents; D002019:Bufexamac